Business Description
Celldex Therapeutics is a New Jersey-based drug development company focused on creating antibody-based treatments for patients suffering from serious inflammatory, allergic, and autoimmune conditions. Its lead programs target diseases driven by mast cells ? a type of immune cell central to allergic responses ? where existing treatments often fall short. The company's pipeline includes two promising drug candidates being studied across conditions such as chronic hives, a severe skin-scratching disorder, and inflammation of the esophagus and skin.
